Why Is the NovaSure Procedure Safer Than Other Methods?
Controversy exists with regard to labeling the safest form of this procedure; however, several physicians have claimed that the NovaSure procedure is a simple and safe, minimally evasive procedure when compared to other endometrial ablation methods.
An evaluation of the data the FDA compiled on various global endometrial ablation methods, including NovaSure, Her Option, HydroThermablator, and Thermachoice, was conducted; according to the Summary of Safety and Effectiveness Data from FDA by J. Cooper and RJ Gimpelson, last updated April 2004 and reported on PubMed.gov:
“At 12 months’ followup, NovaSure and HydroThermablator had the highest amenorrhea rates. Thermachoice and NovaSure had the highest success rates at 12 months. NovaSure had the lowest adverse event rates in the first 24 hours, between 24 hours and 2 weeks and between 2 weeks and 1 year of follow-up.”
There is no need for any incisions. The procedure can be performed within the health care provider’s office in less than five minutes since general anesthetic is not required. Women are not required to take a pretreatment drug to thin the endometrium upwards of two months prior to the ablation. Many women trust NovaSure; in fact, according to the NovaSure website, over one million women have successfully undergone the NovaSure procedure.